Although NK cells may play an important role in delaying RM-1 tumor progression, these cells probably do not play a role in the enhanced antitumoral effect by GPB730 as no differences in NK cell frequency within the tumors was observed between anti-CTLA-4 and the combination anti-CTLA-4 and GPB730 in this study. Here, CTLA4 is linked to neoplasm.